Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Rodman David Malcom sold 20,407 Mineralys Therapeutics, Inc. shares (Form 4)
Traded Jul 13 to Jul 15, 2026 · Filed Jul 15, 2026
From Jul 13 to Jul 15, 2026, Rodman David Malcom (Chief Medical Officer) sold 20,407 Mineralys Therapeutics, Inc. shares at an average US$27.28 for US$557K under a trading plan, leaving 51,384 shares. Filed Jul 15, 2026 (Form 4).
- Sold
- 20,407 shares
- Price
- US$27.28 average (US$26.61 to US$27.58)
- Value
- US$557K
- Holding after
- 51,384 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | Common Stock | Option exercise | 3,542 | US$10.20 | 61,275 | Direct |
| Jul 13, 2026 | Common Stock | Option exercise | 4,167 | US$14.25 | 65,442 | Direct |
| Jul 13, 2026 | Common Stock | Option exercise | 6,349 | US$1.08 | 71,791 | Direct |
| Jul 13, 2026 | Common Stock | Sale | 14,058 | US$27.58 | 57,733 | Direct |
| Jul 15, 2026 | Common Stock | Sale | 6,349 | US$26.61 | 51,384 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Rodman David Malcom
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Rodman David Malcom · Aug 12, 2026
- Form 4 · Rodman David Malcom · Jul 20, 2026
- Form 4 · Rodman David Malcom · Jul 10, 2026
- Form 4 · Rodman David Malcom · Jun 17, 2026
- Form 4 · Rodman David Malcom · Jun 12, 2026
- Form 4 · Peterson Kristine · Oct 20, 2026
- Form 4 · Coats Lonnel · Oct 20, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026